trending Market Intelligence /marketintelligence/en/news-insights/trending/RnwD3OXXAGTSW0cjAYD9XQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Permira-backed Corin to buy Omni Orthopaedics

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Permira-backed Corin to buy Omni Orthopaedics

Corin Group PLC entered into a binding agreement to buy Omni Orthopaedics Inc. in a transaction that is set to close by early March.

Corin is a U.K.-based orthopedic company backed by global investment firm Permira. Omni is a U.S.-based designer, developer and manufacturer of medical devices for the orthopedic industry, with expertise in robotic-assisted knee replacement.

KPMG LLP provided financial and tax advice to Corin, while Barclays Bank PLC provided strategic advice and Skadden Arps Slate Meagher & Flom LLP provided legal advice. Piper Jaffray & Co. was Omni's financial adviser, while Foley Hoag LLP was its legal adviser.